BEBELAC 3 ( 1200G+350G) SER AL DAWAA OFFER
BEBELAC 3 Growing-Up Formula is a scientifically balanced milk formula designed for toddlers aged 1–3 years. It helps support healthy growth, brain development, and daily nutritional needs during an important stage of development.
16.50 د.ا
In stock
Add to wishlist Add to compareAsk about productDescription
BEBELAC 3 is an advanced toddler nutrition formula developed by Danone and offered in this special bundle from Ser Al Dawaa. It is formulated to complement a varied toddler diet and help support nutritional intake when daily meals may not provide all essential nutrients. The formula contains carefully selected vitamins, minerals, and fatty acids that contribute to cognitive development, immune support, and steady physical growth.
Based on pediatric nutrition research, BEBELAC 3 supports digestive comfort and energy levels while providing a mild taste suitable for young children. It is designed for daily use as part of a balanced diet during the transition from infancy to early childhood nutrition.
Product Information
Product Name: BEBELAC 3 Growing-Up Formula (1200g + 350g Offer)
Category: Toddler Milk Formula
Problem it solves:
Helps meet toddlers’ increased nutritional needs when solid food intake alone may be insufficient.
Key Benefits:
-
Supports healthy physical growth
-
Helps support brain and cognitive development
-
Contributes to immune system support
-
Provides balanced vitamins and minerals
-
Helps support digestive comfort
-
Supports daily nutritional intake
Ingredients or Features:
Contains DHA, iron, calcium, and essential vitamins including A, C, and D, formulated for toddlers’ developmental requirements.
How to Use:
Prepare according to package instructions using boiled, cooled water. Mix the recommended number of scoops and serve immediately.
Target Audience:
Children aged 1–3 years.
Requirements:
Use only as directed. Store in a cool, dry place. Consult a healthcare professional if the child has special dietary conditions.






Reviews
There are no reviews yet.